OlympiA

OlympiA

OlympiA is a randomized, double-blind, parallel group, placebo-controlled multi-center phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2  mutations and high risk HER2 negative primary...

NoTOPain

NoTOPain was a randomised, crossover, placebo controlled, double-blind, Phase II study of cetuximab in patients with treatment-refractory, non-malignant severe chronic neuropathic pain.  Neuropathic pain is a subtype of pain that can be caused by a variety of...
APHINITY | Annals of Oncology

APHINITY | Annals of Oncology

Title of Publication Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years’ follow-up AUTHORS Loibl, S; Jassem, J; Sonnenblick, A; Parlier, D; Winer, E; Bergh, J; Gelber, RD; Restuccia, E; Im, YH; Huang,...